Reckitt Benckiser Group (LON:RKT – Free Report) had its price target lowered by Berenberg Bank from GBX 5,200 ($67.51) to GBX 5,177 ($67.22) in a research report report published on Wednesday, MarketBeat Ratings reports. Berenberg Bank currently has a hold rating on the stock.
A number of other research analysts have also recently commented on the company. JPMorgan Chase & Co. cut Reckitt Benckiser Group to a “neutral” rating in a research note on Friday, August 30th. Jefferies Financial Group reissued a “hold” rating and set a GBX 4,400 ($57.13) target price on shares of Reckitt Benckiser Group in a research note on Monday, July 29th.
Get Our Latest Stock Report on RKT
Reckitt Benckiser Group Price Performance
Insider Buying and Selling
In other Reckitt Benckiser Group news, insider Fiona Dawson purchased 25 shares of the firm’s stock in a transaction on Wednesday, October 23rd. The stock was bought at an average price of GBX 4,923 ($63.92) per share, with a total value of £1,230.75 ($1,597.96). 0.05% of the stock is owned by insiders.
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Featured Articles
- Five stocks we like better than Reckitt Benckiser Group
- Canadian Penny Stocks: Can They Make You Rich?
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- 3 Warren Buffett Stocks to Buy Now
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- 3 Healthcare Dividend Stocks to Buy
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.